Literature DB >> 9210654

Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27).

I A Pikuleva1, I Björkhem, M R Waterman.   

Abstract

A large number of microsomal P450s have been expressed in Escherichia coli in quantities sufficient for structure/function analysis. However, only one mitochondrial P450 has been successfully overexpressed, that being cholesterol side chain cleavage cytochrome P450 (P450scc). We report here overexpression, purification, and characterization of a second mitochondrial P450, human sterol C-27 hydroxylase (P450c27). The conditions used for expression are very similar to those applied for P450scc, although a quite different purification protocol was necessary to achieve highly purified P450c27. The catalytic properties of purified recombinant human P450c27 resemble those of purified, endogenous rat and rabbit P450c27, regarding both specificity and turnover numbers. Like endogenous P450c27 from rat and rabbit liver, human recombinant P450c27 is only functional in the presence of adrenodoxin and adrenodoxin reductase and shows no activity in the presence of the microsomal P450 reductase. We conclude that P450c27 is most likely not the 1alpha-hydroxylase of 25-hydroxyvitamin D3, contrary to a previous suggestion (Axen, E., Postlind, H., Sjöberg, H., and Wikvall, K. (1994) Proc. Natl. Acad. Sci. USA 91, 10014-10018) because this activity of P450c27 (28 pmol/min/nmol P450) seems far too low to be physiologically relevant. This activity is 10(3) times lower than the 27-hydroxylase activity toward 5beta-cholestane-3alpha,7alpha,12alpha-triol and 40 times lower than the 27-hydroxylation of cholesterol by this enzyme. The development of this expression system and purification procedure creates the potential for structure/function analysis of P450c27, including possible crystallization of this important enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210654     DOI: 10.1006/abbi.1997.0142

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Authors:  Casey Charvet; Wei-Li Liao; Gun-Young Heo; James Laird; Robert G Salomon; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

2.  Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.

Authors:  Natalia Mast; Kyle W Anderson; Joseph B Lin; Yong Li; Illarion V Turko; Curtis Tatsuoka; Ingemar Bjorkhem; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2017-02-11       Impact factor: 5.157

3.  Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain.

Authors:  Wei-Li Liao; Gun-Young Heo; Nathan G Dodder; Rachel E Reem; Natalia Mast; Suber Huang; Pier Luigi Dipatre; Illarion V Turko; Irina A Pikuleva
Journal:  J Proteome Res       Date:  2010-11-16       Impact factor: 4.466

4.  Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion.

Authors:  Santhosh Sivaramakrishnan; Hugues Ouellet; Hirotoshi Matsumura; Shenheng Guan; Pierre Moënne-Loccoz; Alma L Burlingame; Paul R Ortiz de Montellano
Journal:  J Am Chem Soc       Date:  2012-04-04       Impact factor: 15.419

Review 5.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

6.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

7.  27-Oxygenation of C27-sterols and 25-hydroxylation of vitamin D3 in kidney: cloning, structure and expression of pig kidney CYP27A.

Authors:  H Postlind; F Hosseinpour; M Norlin; K Wikvall
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

8.  Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1.

Authors:  Elaine W Tieu; Wei Li; Jianjun Chen; Donna M Baldisseri; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2011-12-24       Impact factor: 4.292

9.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

10.  Metabolism of a novel side chain modified Delta8(14)-15-ketosterol, a potential cholesterol lowering drug: 28-hydroxylation by CYP27A1.

Authors:  Hanna Pettersson; Maria Norlin; Ulla Andersson; Irina Pikuleva; Ingemar Björkhem; Alexander Yu Misharin; Kjell Wikvall
Journal:  Biochim Biophys Acta       Date:  2008-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.